Repertoire Genesis, Inc. (Osaka, Japan) announced a joint research agreement with the National Institute of Infectious Diseases (Tokyo, Japan). Under this agreement, Repertoire Genesis, Inc. will use its next generation BCR repertoire analysis method, to enable an in-depth investigation of the fully human antibody gene to dengue virus which would be useful for treatment of dengue diseases, and develop more efficient test and diagnostics of dengue virus.